Tarsus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $49.90 |
Previous Close | $49.72 |
Day Range | $49.52-$51.14 |
52W Range | $20.08-$57.28 |
Market Cap | $2B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $182.9M |
Revenue Growth (YoY) | 407.9% |
Gross Profit (12 Mos) | $116.7M |
Diluted EPS | -$3.07 |
News
See moreYahoo Finance • 8 days ago
Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting
Yahoo Finance • 2 months ago
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
Yahoo Finance • 2 months ago
Tarsus Announces Proposed $100.0 Million Public Offering
Yahoo Finance • 2 months ago
Tarsus to Participate in Upcoming Investor Conference
About
CEO | Dr. Bobak R. Azamian M.D. |
CFO | Mr. Jeffrey S. Farrow CPA |
Address | 15440 Laguna Canyon Road, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 323 |
